Minerva Neurosciences NERV
NASDAQ NERV
$2.46 -0.07 (-2.87%)
As of: Oct 21, 2026 · 2:03 PM EDT

Minerva Neurosciences (NERV) EBT Margin (2014 - 2020)

Updated

Minerva Neurosciences (NERV) reported EBT Margin of 4.71% for FY2020.

Analysis

Minerva Neurosciences (NERV) EBT Margin (2014 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,134.61 Bn 1,103.20 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 616.25 Bn 534.77 Bn 17.26 Bn 26.66%
3 AbbVie 501.45 Bn 474.56 Bn 12.70 Bn 25.18%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn 18.19%
7 Amgen 235.87 Bn 191.27 Bn 7.24 Bn 27.53%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -131.41%
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn -4.34%
10 Minerva Neurosciences 114.40 Mn -133.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 71.72%
Dec 31, 2014 -248,200,000.00%
API Access

Minerva Neurosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NERV&period=max&api_key=YOUR_API_KEY